Use of mycobacteriophage quantitative PCR on MGIT broths for a rapid tuberculosis antibiogram

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1523-1528

  Foongladda, Suporn ^a   Klayut, Wiphat ^a   Chinli, Rattapha ^a   Pholwat, Suporn ^b   Houpt, Eric R ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; CULTURE MEDIUM; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIOPHAGE; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; TUBERCULOSIS, MULTIDRUG-RESISTANT; VIROLOGY;

ANTITUBERCULAR AGENTS; CULTURE MEDIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIOPHAGES; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84899529888     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03637-13     Document Type: Article

References (8)

1. Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WC, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Pena J, Perez-Guzman C, Quelapio MI, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, Van der Walt M, Van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ. 2012. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data metaanalysis of 9, 153 patients. PLoS Med. 9:e1001300. http://dx.doi.org/10. 1371/journal.pmed.1001300.
2. Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH, Hollm-Delgado MG, Keshavjee S, DeRiemer K, Centis R, D'Ambrosio L, Lange CG, Bauer M, Menzies D. 2013. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur. Respir. J. 42:156-168. http://dx.doi.org/10.1183/09031936.00134712.
3. Pholwat S, Ehdaie B, Foongladda S, Kelly K, Houpt E. 2012. Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis. J. Clin. Microbiol. 50:754-761. http://dx.doi.org/10.1128/JCM.01315-11.
4. Banu S, Rahman SM, Khan MS, Ferdous SS, Ahmed S, Gratz J, Stroup S, Pholwat S, Heysell SK, Houpt ER. 30 October 2013. Discordance across several drug susceptibility methods for drug-resistant tuberculosis in a single laboratory. J. Clin. Microbiol. http://dx.doi.org/10.1128/JCM.02378-13.
5. Foongladda S, Pholwat S, Eampokalap B, Kiratisin P, Sutthent R. 2009. Multi-probe real-time PCR identificationof common Mycobacterium species in blood culture broth. J. Mol. Diagn. 11:42-48. http://dx.doi.org/10.2353/jmoldx.2009. 080081.
6. World Health Organization. 2008. Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. Document WHO/HTM/TB/2008. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/ publications/2008/whohtmtb-2008-392/en/.
7. CLSI. 2009. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic Actinomycetes; approved standard, vol 20. CLSI, Wayne, PA.
8. Kruuner A, Yates MD, Drobniewski FA. 2006. Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis. J. Clin. Microbiol. 44:811-818. http://dx.doi.org/ 10.1128/JCM.44.3.811-818.2006.